- Home
- PNF vs RFL Comparison
PNF vs RFL Comparison
Compare PNF & RFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PNF
- RFL
- Stock Information
- Founded
- PNF 2001
- RFL 2017
- Country
- PNF United States
- RFL United States
- Employees
- PNF N/A
- RFL N/A
- Industry
- PNF Finance Companies
- RFL Real Estate
- Sector
- PNF Finance
- RFL Finance
- Exchange
- PNF Nasdaq
- RFL Nasdaq
- Market Cap
- PNF 60.0M
- RFL 51.1M
- IPO Year
- PNF N/A
- RFL N/A
- Fundamental
- Price
- PNF $7.70
- RFL $1.99
- Analyst Decision
- PNF
- RFL
- Analyst Count
- PNF 0
- RFL 0
- Target Price
- PNF N/A
- RFL N/A
- AVG Volume (30 Days)
- PNF 29.1K
- RFL 29.7K
- Earning Date
- PNF 01-01-0001
- RFL 03-12-2025
- Dividend Yield
- PNF 5.17%
- RFL N/A
- EPS Growth
- PNF N/A
- RFL N/A
- EPS
- PNF N/A
- RFL N/A
- Revenue
- PNF N/A
- RFL $697,000.00
- Revenue This Year
- PNF N/A
- RFL N/A
- Revenue Next Year
- PNF N/A
- RFL N/A
- P/E Ratio
- PNF N/A
- RFL N/A
- Revenue Growth
- PNF N/A
- RFL 151.62
- 52 Week Low
- PNF $6.37
- RFL $1.29
- 52 Week High
- PNF $9.06
- RFL $2.50
- Technical
- Relative Strength Index (RSI)
- PNF 55.47
- RFL 47.42
- Support Level
- PNF $7.52
- RFL $1.99
- Resistance Level
- PNF $7.72
- RFL $2.12
- Average True Range (ATR)
- PNF 0.08
- RFL 0.09
- MACD
- PNF -0.00
- RFL -0.01
- Stochastic Oscillator
- PNF 52.94
- RFL 50.00
About PNF PIMCO New York Municipal Income Fund
PIMCO New York Municipal Income Fund is a closed-end management investment company. Its investment objective is to seek to provide current income exempt from federal, New York State and New York City income tax. The fund's portfolio of investments consists of investments in different sectors such as education, transportation, healthcare, and others.
About RFL Rafael Holdings Inc. Class B
Rafael Holdings Inc is a holding company with interests in clinical and early-stage pharmaceutical companies. Its primary focus is to expand its investment portfolio through opportunistic investments including therapeutics, which address high unmet medical needs. Through the companies it has invested in, the company is focused on; developing Trappsol Cyclo its clinical program, developing instruments to advance minimally invasive surgeries, preclinical cancer metabolism research operations, and developing pharmaceutical-grade technology Unlokt for third-party cannabis manufacturers. It also holds and manages commercial real estate assets in Jerusalem, Israel. The company's reportable segments are; Infusion Technology, which derives maximum revenue, Healthcare, and Real Estate.